Prairie Pharms, LLC
Nora Springs, IA · Founded 2010 · CIK 0001552063 · Biotech · Private
Small molecule plant extracts containing Thymoquinone derived from USA-grown plants
prairiepharms.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $455K
- 2 Form D · Apr 2016
- 126 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 6
- 3 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20122013201420152016
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $455,000 | |
| Private capital raised | Form D · SEC | $12,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1822 | CUMBERLAND PHARMACEUTICALS, INC. | — | — |
| 1823 | Biohaven Environmental Solutions, LLC | — | $1.4M |
| 1824 | Discgenics, Inc. | — | $870K |
| 1825 | Prairie Pharms, LLC | — | $455K |
| 1826 | Magna Pharmaceuticals, Inc. | — | $1.0M |
| 1827 | CanaQuest Medical Corp. | — | $31K |
| 1828 | NMN Holdings LP | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- John RelherDirector
- Bill RohlfsenExecutive Officer
- Nicholas RohlfsenDirector
- William RohlfsenDirector · Executive Officer
- Joseph SaluriDirector
Patents
- Method For Cultivation Of Monarda Fistulosa For Production Of Thymoquinonegranted
- Method for Cultivation of Monarda Fistulosa for Production of Thymoquinonegranted
- Method For Less Densely Populated Cultivation Of Monarda Fistulosa For Production Of Thymoquinoneapplication
- Methods and Uses of High Thymoquinone and Thymohydroquinone Essential Oil of Monardaapplication
- Method for Cultivation of Monarda Fistulosa for Production of Thymoquinonegranted
- Method For Cultivation Of Monarda Fistulosaapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.